Health ❯ Healthcare ❯ Patient Safety ❯ Medication Risks
Evidence that semaglutide and tirzepatide are linked to fewer alcohol-related hospital admissions and new UK and U.S. access programs have expanded use while leaving budget, safety and long-term benefit concerns unresolved.